DD257430A5 - Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen - Google Patents

Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen Download PDF

Info

Publication number
DD257430A5
DD257430A5 DD87299332A DD29933287A DD257430A5 DD 257430 A5 DD257430 A5 DD 257430A5 DD 87299332 A DD87299332 A DD 87299332A DD 29933287 A DD29933287 A DD 29933287A DD 257430 A5 DD257430 A5 DD 257430A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
lower alkyl
hydrogen
compounds
compound
Prior art date
Application number
DD87299332A
Other languages
German (de)
English (en)
Inventor
Wasley
Norman
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD257430A5 publication Critical patent/DD257430A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DD87299332A 1986-01-21 1987-01-19 Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen DD257430A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/821,110 US4758559A (en) 1986-01-21 1986-01-21 Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors

Publications (1)

Publication Number Publication Date
DD257430A5 true DD257430A5 (de) 1988-06-15

Family

ID=25232538

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87299332A DD257430A5 (de) 1986-01-21 1987-01-19 Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen

Country Status (25)

Country Link
US (1) US4758559A (fi)
EP (1) EP0233483B1 (fi)
JP (2) JPH0780888B2 (fi)
KR (1) KR900004148B1 (fi)
AT (1) ATE62244T1 (fi)
AU (1) AU598510B2 (fi)
CA (1) CA1273335A (fi)
CY (1) CY1749A (fi)
DD (1) DD257430A5 (fi)
DE (1) DE3768978D1 (fi)
DK (1) DK169239B1 (fi)
ES (1) ES2039363T3 (fi)
FI (1) FI86636C (fi)
GR (1) GR3001737T3 (fi)
HK (1) HK24194A (fi)
HU (1) HU198061B (fi)
IE (1) IE59653B1 (fi)
IL (1) IL81302A (fi)
MA (1) MA20857A1 (fi)
MY (1) MY100914A (fi)
PH (1) PH25148A (fi)
PT (1) PT84136B (fi)
TN (1) TNSN87003A1 (fi)
ZA (1) ZA87389B (fi)
ZW (1) ZW787A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332792T2 (de) * 1992-04-20 2004-01-15 Takeda Chemical Industries Ltd 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide
US5452434A (en) * 1992-07-14 1995-09-19 Advanced Micro Devices, Inc. Clock control for power savings in high performance central processing units
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5439524A (en) * 1993-04-05 1995-08-08 Vlsi Technology, Inc. Plasma processing apparatus
US5698518A (en) * 1994-03-30 1997-12-16 Oklahoma Medical Research Foundation Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5624902A (en) * 1995-06-07 1997-04-29 Torrey Pines Institute For Molecular Studies Peptide inhibitors of calmodulin
US6423329B1 (en) 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029672A (en) * 1976-02-26 1977-06-14 American Hoechst Corporation Aminoalkylpyrrolobenzoxazalkanes
US4045448A (en) * 1976-02-26 1977-08-30 American Hoechst Corporation Pyrrolo[2,1-c][1,4]benzoxazepine and benzoxazocine derivatives
US4053599A (en) * 1976-02-26 1977-10-11 American Hoechst Corporation Piperazionalkylpyrrolobenzoxazalkanes
US4169095A (en) * 1977-01-19 1979-09-25 American Hoechst Corporation Process for preparing aminoalkylpyrrolobenzoxazalkanes
US4608374A (en) * 1983-11-07 1986-08-26 Hoechst-Roussel Pharmaceuticals Inc. 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents

Also Published As

Publication number Publication date
MY100914A (en) 1991-05-31
PT84136B (pt) 1989-07-31
AU6781387A (en) 1987-07-23
ATE62244T1 (de) 1991-04-15
IE870139L (en) 1987-07-21
IL81302A (en) 1990-11-29
PH25148A (en) 1991-03-13
EP0233483B1 (de) 1991-04-03
GR3001737T3 (en) 1992-11-23
ZW787A1 (en) 1987-08-12
HK24194A (en) 1994-03-25
AU598510B2 (en) 1990-06-28
IL81302A0 (en) 1987-08-31
TNSN87003A1 (fr) 1990-01-01
DK29587A (da) 1987-07-22
FI870207A0 (fi) 1987-01-19
JPH0826028B2 (ja) 1996-03-13
KR870007181A (ko) 1987-08-17
FI870207A (fi) 1987-07-22
HUT45259A (en) 1988-06-28
PT84136A (en) 1987-02-01
DE3768978D1 (de) 1991-05-08
IE59653B1 (en) 1994-03-09
HU198061B (en) 1989-07-28
CY1749A (en) 1994-06-03
ES2039363T3 (es) 1995-04-01
ZA87389B (en) 1987-11-25
DK29587D0 (da) 1987-01-20
JPS62169791A (ja) 1987-07-25
MA20857A1 (fr) 1987-10-01
EP0233483A3 (en) 1988-10-19
EP0233483A2 (de) 1987-08-26
DK169239B1 (da) 1994-09-19
JPH0789966A (ja) 1995-04-04
JPH0780888B2 (ja) 1995-08-30
FI86636C (fi) 1992-09-25
CA1273335A (en) 1990-08-28
US4758559A (en) 1988-07-19
KR900004148B1 (ko) 1990-06-16
FI86636B (fi) 1992-06-15

Similar Documents

Publication Publication Date Title
DE2614406C2 (fi)
DE2760372C2 (fi)
EP0136658B1 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE3839385A1 (de) Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE3145678A1 (de) Dibenzazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
EP0233483B1 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DE3422411A1 (de) Spirosuccinimide, ihre herstellung und verwendung
DD299427A5 (de) Neue 1-oxa-2-oxo-8-aza-spiro(4,5)dekan-derivate und verfahren zu ihrer herstellung
DD263289A5 (de) Verfahren zur herstellung disubstituierter piperazine
DE2822465C2 (de) 2-substituierte trans-5-Phenyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indolderivate und diese enthaltende Arzneimittel
CH643553A5 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel.
EP0170861B1 (de) 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0110869A1 (de) Thienylessigsäureamidderivate und pharmazeutisch verträgliche Säureadditionssalze hiervon sowie Verfahren zu deren Herstellung
DE3705934A1 (de) Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0389425B1 (de) Neue Benzothiopyranylamine
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
DE3028064C2 (fi)
DE2349493A1 (de) 2-(2-pyridyl)- omega-phenylalkylamine und verfahren zu ihrer herstellung
DD297813A5 (de) Verfahren zur herstellung von dihydropyridinamiden
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
DE2605824C3 (de) N-Acylaniline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0037990A1 (de) Phenyl-chinolizidine, entsprechende pharmazeutische Präparate, die Herstellung der Wirkstoffe sowie entsprechende Ausgangsverbindungen
DE2308064C3 (de) Benzotriazole, ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel